|
|
| (5 intermediate revisions by one user not shown) |
| Line 1: |
Line 1: |
| − | Potentially Inappropriate Medication (PIM) Use in Older Adults: 65 and Older - Independent of Diagnoses or Conditions - Based on Upated Beers Criteria
| + | #REDIRECT [[CDS]] |
| − | | + | |
| − | | + | |
| − | '''''Back to'''''
| + | |
| − | | + | |
| − | [[:CDS|CDS]]
| + | |
| − | | + | |
| − | [[:CDS#Medication-Based_Safety_Rules|Medication-Based Safety Rules]]
| + | |
| − | | + | |
| − | ----
| + | |
| − | | + | |
| − | =====Potentially inappropriate medication use in adults 65 years and older in the United States based on revised and updated 2000 [http://www.medterms.com/script/main/art.asp?articlekey=38375 Beers criteria.]=====
| + | |
| − | | + | |
| − | The Beers criteria are based on expert consensus developed through an extensive literature review with a
| + | |
| − | | + | |
| − | bibliography and questionnaire evaluated
| + | |
| − | by nationally recognized experts in geriatric care, clinical pharmacology, and psychopharmacology using a
| + | |
| − | | + | |
| − | modified Delphi technique to reach consensus.
| + | |
| − | | + | |
| − | The Beers criteria have been used to survey clinical medication use, analyze computerized administrative data
| + | |
| − | | + | |
| − | sets, and evaluate intervention studies to decrease medication problems in older adults.
| + | |
| − | | + | |
| − | With the continuous arrival of new drugs on the market, increased knowledge about older drugs, and removal of
| + | |
| − | | + | |
| − | older drugs from the market, these criteria go through updates on a regular basis to remain useful. Since the
| + | |
| − | | + | |
| − | criteria were published in 1997, there has been an increase in the number of scientific studies addressing
| + | |
| − | | + | |
| − | drug use and appropriateness in older adults, but there is still a lack of controlled studies in the older
| + | |
| − | | + | |
| − | population and particularly in patients older than 75 years and patients with multiple comorbidities.
| + | |
| − | | + | |
| − | An initiative by [http://archinte.ama-assn.org/cgi/content/full/163/22/2716 Donna M. Fick, PhD, RN, et al.]to
| + | |
| − | | + | |
| − | revise and update the Beers criteria for ambulatory and nursing facility populations older than 65 years in
| + | |
| − | | + | |
| − | the United States aimed to:
| + | |
| − | | + | |
| − | (1) To reevaluate the 1997 criteria to include new products and incorporate new information available from the
| + | |
| − | | + | |
| − | scientific literature.
| + | |
| − | | + | |
| − | (2) To assign or reevaluate a relative rating of severity for each of the medications.
| + | |
| − | | + | |
| − | (3) To identify any new conditions or considerations not addressed in the 1997 criteria.
| + | |
| − | | + | |
| − | | + | |
| − | The list below contains medications or medication classes that should generally be avoided in persons 65 years
| + | |
| − | | + | |
| − | or older because they are either ineffective or they pose unnecessarily high risk for older persons and a
| + | |
| − | | + | |
| − | safer alternative is available. They are concluded to be inappropriate to use independent of diagnoses or
| + | |
| − | | + | |
| − | conditions and marked with HIGH Severity Rating of Adverse drug events (ADEs).
| + | |
| − | | + | |
| − | | + | |
| − | '''Table Definitions'''
| + | |
| − | '''Drug Name''': is the Drug Brand Name.
| + | |
| − | '''Other Name (Generic)''': is the generic name of the drug.
| + | |
| − | '''Drug Class & Similarity''': drug class is listed if the whole class considered high risk.
| + | |
| − | '''Doses, Exceptions & Other''': ranges for high-risk doses, exceptions, and/or other applicable conditions.
| + | |
| − | '''Concerns and Rules''' : Link to the concerns about this drug and possible rules use and alternatives.
| + | |
| − | | + | |
| − | ----
| + | |
| − | | + | |
| − | '''Aiman Alrawabdeh 5/28/2006'''
| + | |
| − | | + | |
| − | ----
| + | |
| − | | + | |
| − | ====References====
| + | |
| − | [http://archinte.ama-assn.org/cgi/content/full/163/22/2716 Donna M. Fick, PhD, RN, et al. Updating the Beers
| + | |
| − | | + | |
| − | Criteria for Potentially Inappropriate Medication Use in Older Adults:Results of a US Consensus Panel of
| + | |
| − | | + | |
| − | Experts. Archives of Interal Medicine. 2003;163:2716-2724]
| + | |
| − | | + | |
| − | [[Category:OHSU-SP-06]]
| + | |
| − | [[Category:CDS]]
| + | |
| − | [[Category:Medication-Based Safety Rules]]
| + | |
| − | | + | |
| − | ----
| + | |
| − | '''''Back to'''''
| + | |
| − | | + | |
| − | [[:CDS|CDS]]
| + | |
| − | | + | |
| − | [[:CDS#Medication-Based_Safety_Rules|Medication-Based Safety Rules]]
| + | |
| − | | + | |
| − | ----
| + | |
| − | | + | |
| − | ==The Rule==
| + | |
| − | | + | |
| − | The Patient: is Male or Female in the USA
| + | |
| − | And
| + | |
| − | Age : 65 years and older
| + | |
| − | And
| + | |
| − | Condition : patient has Only the condition(s) that are intended to be treated by one or
| + | |
| − | more drug listed below
| + | |
| − | And
| + | |
| − | Drug : Brand name, the Generic name or – a drug – from the listed drug classes
| + | |
| − | And
| + | |
| − | Condition (if any) are met under Field “Doses, Exceptions & Other”
| + | |
| − | Then
| + | |
| − | Click on the Link under the Hyper-Link “Concern and Rules” Field marked with the
| + | |
| − | Brand Name: Generic Name
| + | |
| − | To view the concerns about this drug and possible rules use and alternatives
| + | |
| − | | + | |
| − | | + | |
| − | ==List of Drugs By Brand Name==
| + | |
| − | <table style="background-color: FFFFFF;" border="4">
| + | |
| − | <th align=left>Drug Name </th><th align=left>Other Name (Generic)</th><th align=left>Drug Class &
| + | |
| − | | + | |
| − | Similarity</th><th align=left>Doses, Exceptions & Other</th><th align=center>Concerns and Rules for
| + | |
| − | | + | |
| − | Drug_Name:Generic_Name</th>
| + | |
| − | <tr><td align=left> Adalat </td><td align=left> Nifedipine </td><td align=left> Similar to:Procardia
| + | |
| − | | + | |
| − | </td><td align=left> Short acting</td><td align=left>'''[[Adalat:Nifedipine]]'''
| + | |
| − | <tr><td align=left> Aldomet </td><td align=left> Methyldopa </td><td align=left> Similar to:Aldoril </td><td
| + | |
| − | | + | |
| − | align=left> NA </td><td align=left>'''[[ Aldomet : Methyldopa ]]'''
| + | |
| − | <tr><td align=left> Aldoril </td><td align=left> Methyldopa-hydrochlorothiazide </td><td align=left> Similar
| + | |
| − | | + | |
| − | to:Aldomet </td><td align=left> NA </td><td align=left>'''[[ Aldoril : Methyldopa-hydrochlorothiazide ]]'''
| + | |
| − | <tr><td align=left> Aleve </td><td align=left> Naproxen </td><td align=left> Non-COX-selective NSAIDs
| + | |
| − | | + | |
| − | (Non-Cyclooxygenase-Selective Nonsteroidal Anti-Inflammatory Drugs) </td><td align=left> Long-term use of
| + | |
| − | | + | |
| − | full-dosage, longer half-life </td><td align=left>'''[[ Aleve : Naproxen ]]'''
| + | |
| − | <tr><td align=left> Amphetamines </td><td align=left> Amphetamines </td><td align=left> Excluding :
| + | |
| − | | + | |
| − | Methylphenidate hydrochloride and Excluding : Anorexics </td><td align=left> NA </td><td align=left>'''[[ Amphetamines : Amphetamines ]]'''
| + | |
